Hirschsprung disease is a condition in which certain nerve fibers are absent in the segment of the bowel results in partial or full blockage of a stool which further leads to severe infection and damage to the colon. The condition is present at the newborn period and later in infancy and childhood as a result of missing nerve cells in the muscles of the baby's colon, and children are prone to a severe intestinal infection called enterocolitis which can be a life threatening.
Mortality from enterocolitis or surgical complications in infancy is 25-30%. Hirschsprung disease is a common cause of chronic constipation. Hirschsprung's disease is associated with certain inherited conditions, such as Down syndrome and other abnormalities present at birth, such as congenital heart disease.
Hirschsprung’s disease occurs once in every 5,000 live births and is about four times more common in males than females.Hirschsprung disease affects all races; however, it is roughly three times more common among Asian-Americans. The main signs and symptoms of Hirschsprung disease are constipation or intestinal obstruction, usually appearing shortly after birth.
Most often, an infant or a child with Hirschsprung disease will have other symptoms, including growth failure, swelling of the abdomen, unexplained fever, or vomiting. However, Hirschsprung disease can be treated, depending on the bowel condition and its severity and based on the patient's symptoms and medical history; this is expected to reflect positive growth in the global Hirschsprung disease treatmentmarket.
Technology advancements in healthcare related to research and development of new therapies and drugs are now curing life-threatening diseases and giving promising results. Increasing the prevalence rate of such diseases with increasing number of diagnosed infants with Hirschsprung Disease across the globe are driving the Hirschsprung Disease Treatment market.
However, some of the restraints also are there that hamper the Hirschsprung Disease Treatmentmarket growth such factor are the lack of definitive treatment options & misdiagnosis of the diseaseand limited access to healthcare services in various countries.
Continuous investment by government in clinical research to get the new ways to prevent, detect, or treat disease. Researchers also use clinical trials to look at other aspects of care, such as improving the quality of life for people with chronic illnesses.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other components of the National Institutes of Health (NIH) conduct and support research into such diseases and conditions. This is expected to drive the growth of Hirschsprung Disease Treatmentmarket during the forecast period.
Prognosis of Hirschsprung Disease with the help of diagnostic tests at regular intervals is also expected to propel the Hirschsprung Disease Treatment market.
Based on geography, Hirschsprung Disease Treatment market has been segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, and Middle East & Africa. North America is relied upon to represent tremendous commitment under Hirschsprung Disease Treatment by income era due to well-developed diagnosis and treatment centers with affordability to health care facilities.
Stimulated advancement in old technology and increasing awareness about disorders through government in Europe exhibits the rise of the Hirschsprung Disease Treatmentmarket. China, India are also relied upon to show high development rate, because of increases in research centers and adoption of these procedures in clinical practice with improved clinical outcomes that would push the Hirschsprung Disease Treatment market growth.
Some of the major key players of Hirschsprung Disease Treatment market constitute: Pfizer, Sanofi, Bayer Healthcare, Johnson and Johnson Merck & Co., Novartis AG, Bristol-Myers Squibb, Astellas Pharma, Inc., Eli Lilly and Company, Abbott, Panacea Biotech Ltd. Cipla Ltd., GlaxoSmithKline Dr. Reddy’s Laboratories Ltd, and Baxter International.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global market for Hirschsprung Disease Treatment is segmented on the basis of Drug Class, Distribution Channel, and geography:
Based on Drug Class, Hirschsprung Disease Treatment market is segmented into the following:
Based on Distribution Channel, Hirschsprung Disease Treatment market is segmented into the following:
Explore Similar Insights
Hirschsprung Disease Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
